重組蛋白生產服務市場－全球產業規模、佔有率、趨勢、機會和預測，按服務類型、宿主細胞、最終用戶、地區和競爭格局分類，2020-2030年預測

2024年全球重組蛋白生產服務市場規模為37.6億美元，預計2030年將以7.41%的複合年成長率成長至57.7億美元。重組蛋白是透過將特定遺傳物質導入宿主細胞而人工合成的蛋白質，從而能夠大規模生產，用於包括治療、診斷和研究在內的多種用途。該領域生產服務市場的主要促進因素包括：全球生物製藥研發投資的不斷成長、對生物製劑和生物相似藥需求的持續擴大，以及需要先進蛋白質療法的慢性疾病日益增加。

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球重組蛋白生產服務市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按服務類型（臨床前和臨床服務、商業生產服務）
  • 依宿主細胞類型（哺乳動物細胞、細菌細胞、昆蟲細胞、酵母和真菌、其他）
  • 按最終用戶（製藥和生物技術公司、學術和研究機構）分類
  • 按地區
  • 按公司（2024 年）
• 市場地圖

第6章：北美重組蛋白生產服務市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲重組蛋白生產服務市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區重組蛋白生產服務市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲重組蛋白生產服務市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲重組蛋白生產服務市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章：市場動態

• 促進要素
• 挑戰

第12章：市場趨勢與發展

• 併購（如有）
• 產品發布（如有）
• 最新進展

第13章：全球重組蛋白生產服務市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商議價能力
• 顧客的力量
• 替代產品的威脅

第15章：競爭格局

• Lonza Group Ltd.
• Boehringer Ingelheim International GmbH
• FUJIFILM Diosynth Biotechnologies USA, Inc.
• Merck KGaA
• Bruker Corporation
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Kaneka Corporation
• Polyplus Transfection SA
• Boster Biological Technology Co., Ltd.

第16章：策略建議

第17章調查會社について,免責事項

The Global Recombinant Proteins Manufacturing Services Market, valued at USD 3.76 Billion in 2024, is projected to experience a CAGR of 7.41% to reach USD 5.77 Billion by 2030. Recombinant proteins are artificially engineered proteins generated by introducing specific genetic material into host cells, enabling their large-scale production for diverse applications, including therapeutic, diagnostic, and research purposes. The market for manufacturing services in this sector is fundamentally driven by increasing global investments in biopharmaceutical research and development, the expanding demand for biologics and biosimilars, and the growing prevalence of chronic diseases requiring advanced protein-based therapies.

Key Market Drivers

The rising demand for biologics and biosimilars is a primary driver for the global recombinant proteins manufacturing services market. These advanced therapeutic products, leveraging recombinant protein technology, address diverse diseases, and their growing adoption demands specialized production capabilities. Patent expirations for originator biologics have notably fueled the biosimilars sector, increasing product development. Recombinant protein service manufacturers are crucial in supporting this pipeline, providing expertise and infrastructure for complex biological production. This pursuit of more affordable treatments strengthens market demand; according to a study published by RAND Corporation in January 2022, biosimilar drugs are expected to generate savings estimated at USD 38.4 billion of projected total U. S. expenditure on biologics from 2021 to 2025. This economic benefit underscores the need for efficient and scalable manufacturing services.

Key Market Challenges

The inherent complexities in achieving optimal protein expression, ensuring high purity during purification, and maintaining consistent product quality and stability pose a significant impediment to the growth of the global recombinant proteins manufacturing services market. These technical hurdles, including issues such as protein aggregation and the necessity for stringent regulatory compliance across diverse expression systems, directly lead to elevated operational costs and extended development timelines for recombinant protein products. This significantly increases the financial burden on manufacturers and developers.

Key Market Trends

The expansion of biopharmaceutical outsourcing to specialized providers continues to significantly shape the Global Recombinant Proteins Manufacturing Services Market. This trend reflects a strategic shift by pharmaceutical and biotechnology companies to leverage external expertise, advanced technologies, and scalable capacity offered by contract development and manufacturing organizations. This allows companies to optimize resource allocation, reduce capital expenditure, and accelerate time to market for complex protein-based therapies. Lonza's CDMO business, for instance, reported robust performance in its first half of 2025, with sales delivering a 23.1% growth at constant exchange rates. This substantial growth underscores the sustained demand for specialized outsourcing services within the industry.

Key Market Players

• Lonza Group Ltd.
• Boehringer Ingelheim International GmbH
• FUJIFILM Diosynth Biotechnologies USA, Inc.
• Merck KGaA
• Bruker Corporation
• Sino Biological, Inc.
• GenScript Biotech Corporation
• Kaneka Corporation
• Polyplus Transfection S.A.
• Boster Biological Technology Co., Ltd.

Report Scope:

In this report, the Global Recombinant Proteins Manufacturing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Recombinant Proteins Manufacturing Services Market, By Service Type:

• Pre-clinical & Clinical Services
• Commercial Production Services

Recombinant Proteins Manufacturing Services Market, By Host Cell:

• Mammalian Cells
• Bacterial Cells
• Insect Cells
• Yeast & Fungi
• Others

Recombinant Proteins Manufacturing Services Market, By End-user:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes

Recombinant Proteins Manufacturing Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Recombinant Proteins Manufacturing Services Market.

Available Customizations:

Global Recombinant Proteins Manufacturing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Recombinant Proteins Manufacturing Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service Type (Pre-clinical & Clinical Services, Commercial Production Services)
  • 5.2.2. By Host Cell (Mammalian Cells, Bacterial Cells, Insect Cells, Yeast & Fungi, Others)
  • 5.2.3. By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Recombinant Proteins Manufacturing Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service Type
  • 6.2.2. By Host Cell
  • 6.2.3. By End-user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service Type
      • 6.3.1.2.2. By Host Cell
      • 6.3.1.2.3. By End-user
  • 6.3.2. Canada Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service Type
      • 6.3.2.2.2. By Host Cell
      • 6.3.2.2.3. By End-user
  • 6.3.3. Mexico Recombinant Proteins Manufacturing Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service Type
      • 6.3.3.2.2. By Host Cell
      • 6.3.3.2.3. By End-user

7. Europe Recombinant Proteins Manufacturing Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service Type
  • 7.2.2. By Host Cell
  • 7.2.3. By End-user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service Type
      • 7.3.1.2.2. By Host Cell
      • 7.3.1.2.3. By End-user
  • 7.3.2. France Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service Type
      • 7.3.2.2.2. By Host Cell
      • 7.3.2.2.3. By End-user
  • 7.3.3. United Kingdom Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service Type
      • 7.3.3.2.2. By Host Cell
      • 7.3.3.2.3. By End-user
  • 7.3.4. Italy Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service Type
      • 7.3.4.2.2. By Host Cell
      • 7.3.4.2.3. By End-user
  • 7.3.5. Spain Recombinant Proteins Manufacturing Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service Type
      • 7.3.5.2.2. By Host Cell
      • 7.3.5.2.3. By End-user

8. Asia Pacific Recombinant Proteins Manufacturing Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service Type
  • 8.2.2. By Host Cell
  • 8.2.3. By End-user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service Type
      • 8.3.1.2.2. By Host Cell
      • 8.3.1.2.3. By End-user
  • 8.3.2. India Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service Type
      • 8.3.2.2.2. By Host Cell
      • 8.3.2.2.3. By End-user
  • 8.3.3. Japan Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service Type
      • 8.3.3.2.2. By Host Cell
      • 8.3.3.2.3. By End-user
  • 8.3.4. South Korea Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service Type
      • 8.3.4.2.2. By Host Cell
      • 8.3.4.2.3. By End-user
  • 8.3.5. Australia Recombinant Proteins Manufacturing Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service Type
      • 8.3.5.2.2. By Host Cell
      • 8.3.5.2.3. By End-user

9. Middle East & Africa Recombinant Proteins Manufacturing Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service Type
  • 9.2.2. By Host Cell
  • 9.2.3. By End-user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service Type
      • 9.3.1.2.2. By Host Cell
      • 9.3.1.2.3. By End-user
  • 9.3.2. UAE Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service Type
      • 9.3.2.2.2. By Host Cell
      • 9.3.2.2.3. By End-user
  • 9.3.3. South Africa Recombinant Proteins Manufacturing Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service Type
      • 9.3.3.2.2. By Host Cell
      • 9.3.3.2.3. By End-user

10. South America Recombinant Proteins Manufacturing Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service Type
  • 10.2.2. By Host Cell
  • 10.2.3. By End-user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service Type
      • 10.3.1.2.2. By Host Cell
      • 10.3.1.2.3. By End-user
  • 10.3.2. Colombia Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service Type
      • 10.3.2.2.2. By Host Cell
      • 10.3.2.2.3. By End-user
  • 10.3.3. Argentina Recombinant Proteins Manufacturing Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service Type
      • 10.3.3.2.2. By Host Cell
      • 10.3.3.2.3. By End-user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Recombinant Proteins Manufacturing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Lonza Group Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. FUJIFILM Diosynth Biotechnologies USA, Inc.
• 15.4. Merck KGaA
• 15.5. Bruker Corporation
• 15.6. Sino Biological, Inc.
• 15.7. GenScript Biotech Corporation
• 15.8. Kaneka Corporation
• 15.9. Polyplus Transfection S.A.
• 15.10. Boster Biological Technology Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer